US Biopharmaceutical Finance and the Sustainability of the Biotech Business Model

The price of innovation: new estimates of drug development costs

Joseph A. DiMasi, Ronald W. Hansen, Henry G. Grabowski · Journal of Health Economics · 2003 · 4.3K citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +14

Knowledge Networks as Channels and Conduits: The Effects of Spillovers in the Boston Biotechnology Community

Jason Owen‐Smith, Walter W. Powell · Organization Science · 2004 · 2.2K citations

Management, Biotechnology, Innovation Management +17

Information Asymmetry, R&D, and Insider Gains

David Aboody, Baruch Lev · The Journal of Finance · 2000 · 1.6K citations · Full text

Business, Accountancy, Strategy +17

Contagious Speculation and a Cure for Cancer: A Nonevent that Made Stock Prices Soar

Gur Huberman, Tomer Regev · The Journal of Finance · 2001 · 987 citations

Life Sciences, Biotechnology, Oncology +7

On the Complex Economics of Patent Scope

Robert P. Merges, Richard R. Nelson · Columbia Law Review · 1990 · 940 citations

Management, Business Economics, Economics +11